$STSN StemSation International Provides Corporate

New Post Public Reply Private Reply Replies (0) Message Board
louied91
140
$STSN StemSation International Provides Corporate Updates

https://www.globenewswire.com/news-release/20...dates.html

PLANTATION, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing new business initiatives for the upcoming months.

"We announced last year that we had streamlined our current business and would be seeking further licensing opportunities and asset acquisitions,” stated Benjamin Silber, CEO of StemSation International. “Working closely with advisors, we are concentrating on business segments with proven growth. While we had targeted green energy companies as our initial acquisition targets, we have not found the right fit yet for the company,” he continued. “As we work on the roll-out of our consumer goods products, we have found some opportunities in this space that allow for the current acquisition of consumer products companies while providing a distribution platform for future StemSation products. The focus would be ‘impulse buy’ products by the cash registers of convenience stores. We expect to have updates shortly as we move these projects forward,” he concluded.

According to newly released data from the National Association of Convenience Stores (NACS), convenience stores saw record sales in stores in 2023. Total convenience industry sales in 2023 were $859.8 billion, of which $327.6 billion were from in-store sales. The display space around the cashier is the most crucial area in the store to build incremental sales. There is a sales advantage at the register space because the customer has already committed to making a purchase. At this point, the store is leveraging impulse behaviors to increase incremental sales.

StemSation expects to have additional updates shortly as they fulfill on their current business plan.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading